In addition to that the rescheduling of cannabis from Schedule I to III or IV should get the sector moving in a big way. That will open the doors wide for medical R&D, and new drug products hitting the market. Epidiolex won't be able to be prescribed unless they reschedule marijuana because it's made from the plant. They HAVE to reschedule it.
(2)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links